Targeting Oncogenic Src Homology 2 Domain-Containing Phosphatase 2 (SHP2) by Inhibiting Its Protein-Protein InteractionsInflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defectsExpanding the molecular spectrum of pathogenic SHOC2 variants underlying Mazzanti syndromeModeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2
author
type
label
Maja Solman